High-risk patients ages 40-59 should speak with their physicians and make an individual decision about whether to start a daily aspirin regimen, the draft guidelines say. The task force also proposed that such a regimen not be used for patients 60 or older, citing the risk of life-threatening bleeding, which increases with age. The task force previously recommended people in this age group consult with their physicians before starting low-dose aspirin.
The proposed changes are based on mounting evidence that shows low-dose aspirin has a small net benefit for high-risk patients in their 40s and 50s and no net benefit for patients 60 and over.
The draft guidelines would not apply to people already taking low-dose aspirin or those who have had a heart attack.
The task force has also proposed updating a 2016 recommendation to use low-dose aspirin for colorectal cancer prevention.
The draft guidelines are open for public comment until Nov. 8.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
